During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant-ineligible B-cell lymphoma.

A new study published in Nature Cancer reveals that age-related metabolic decline impairs the efficacy of CAR-T cell therapy.

Personalized medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools.

Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a ...

In biology classes from high school through university, I learned that mitochondria are little objects that reside within ...

It was announced that the live-action movie adaptation of Akane Shimizu’s Cells at Work! manga series is coming to Netflix! The movie is slated to premiere on the streaming service on June 13! An ...

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported ...

First Steps director Matt Shakman has confirmed that the movie will feature more than one H.E.R.B.I.E., and along with ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

IL-21, Interleukin-21; Tfh cells, Follicular helper T; Th17, T helper 17; MHC, Major Histocompatibility Complex; NK cells, Natural Killer cells; AMR, Antibody Mediated Rejection; ROCK2, Rho Associated ...

1Department of Otolaryngology—Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota. 2Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.